FdaApplication
NDA 219141
Identifiers
- fda_app_no: NDA219141
Properties
| Property | Value |
|---|---|
| applicant_name | NOVITIUM PHARMA LLC |
| application_type | NDA |
| approval_date | 2025-01-28 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| INZIRQO | HYDROCHLOROTHIAZIDE | 10MG/ML | FOR SUSPENSION;ORAL |
1 product